Tenax Therapeutics Inc. (TENX) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS
Tenax Therapeutics Inc. (NASDAQ:TENX) released its quarterly earnings data on Thursday. The specialty pharmaceutical company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.17) by $0.02.
Shares of Tenax Therapeutics (NASDAQ:TENX) opened at 1.49 on Thursday. The stock’s 50 day moving average price is $1.95 and its 200 day moving average price is $2.39. Tenax Therapeutics has a 1-year low of $1.34 and a 1-year high of $3.40. The company’s market capitalization is $41.90 million.
About Tenax Therapeutics
Tenax Therapeutics Inc, formerly Oxygen Biotherapeutics, Inc, is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care patients. The Company’s principal business is to acquire, or discover, develop, and commercialize novel therapeutic products for disease indications that represent significant areas of clinical need and commercial opportunity.
Receive News & Stock Ratings for Tenax Therapeutics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenax Therapeutics Inc. and related stocks with our FREE daily email newsletter.